Ash Ramzan, founder of Woodley BioReg, a global leader in regulatory compliance and quality assurance, has been invited to speak at the upcoming ‘Selling to the UK’ webinar, taking place on March 12th.
Organised in collaboration with the Department for Business and Trade, British Consulate General Chongqing, this event aims to guide Chinese pharmaceutical companies on entering the UK market.
With extensive experience in regulatory strategy and commercialisation, Ash will provide expert insights on market access (MA), clinical trials, pricing, marketing and sales costs, patient needs, and commercialisation opportunities.
Woodley BioReg has a strong global presence, including established partnerships in East Asia, making Ash’s perspective particularly valuable for companies looking to navigate the UK’s highly regulated pharmaceutical landscape.
As Chinese pharmaceutical firms face increasing domestic challenges – ranging from intense market competition to evolving regulatory frameworks – expanding into the UK presents exciting new opportunities.
This session will help UK consultancies engage with Chinese pharma while also encouraging foreign direct investment (FDI) by supporting Chinese companies in setting up UK operations for sales (phase 1) and R&D activities (phase 2).
This webinar is a must-attend event for Chinese businesses looking to understand the UK’s pharmaceutical market and connect with leading industry experts.
For more details or to register, please contact enquiry@woodleybioreg.com
Back to News + Insights